newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laur